Ameriprise
BME icon

Ameriprise’s BlackRock Health Sciences Trust BME Stock Holding History

Ameriprise’s Portfolio BME Stock Details BME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.66M Sell
68,984
-588
-0.8% -$24.2K ﹤0.01% 2819
2025
Q4 		$2.86M Buy
69,572
+564
+0.8% +$22.3K ﹤0.01% 2808
2025
Q3 		$2.57M Sell
69,008
-1,944
-3% -$70.6K ﹤0.01% 2879
2025
Q2 		$2.59M Buy
70,952
+3,342
+5% +$121K ﹤0.01% 2802
2025
Q1 		$2.61M Sell
67,610
-105,219
-61% -$4.17M ﹤0.01% 2752
2024
Q4 		$6.55M Buy
172,829
+8,622
+5% +$344K ﹤0.01% 2154
2024
Q3 		$6.89M Buy
164,207
+5,004
+3% +$208K ﹤0.01% 2140
2024
Q2 		$6.5M Sell
159,203
-18,337
-10% -$730K ﹤0.01% 2099
2024
Q1 		$7.36M Buy
177,540
+21,196
+14% +$888K ﹤0.01% 2066
2023
Q4 		$6.32M Sell
156,344
-19,005
-11% -$726K ﹤0.01% 2178
2023
Q3 		$6.86M Buy
175,349
+28,631
+20% +$1.14M ﹤0.01% 2032
2023
Q2 		$5.96M Buy
146,718
+14,430
+11% +$594K ﹤0.01% 2207
2023
Q1 		$5.54M Sell
132,288
-3,941
-3% -$166K ﹤0.01% 2248
2022
Q4 		$5.94M Buy
136,229
+10,250
+8% +$436K ﹤0.01% 2170
2022
Q3 		$4.89M Sell
125,979
-88,323
-41% -$3.76M ﹤0.01% 2240
2022
Q2 		$9.09M Buy
214,302
+96,132
+81% +$4.18M ﹤0.01% 1818
2022
Q1 		$5.38M Buy
118,170
+25,277
+27% +$1.12M ﹤0.01% 2374
2021
Q4 		$4.5M Buy
92,893
+4,865
+6% +$230K ﹤0.01% 2541
2021
Q3 		$4.19M Buy
88,028
+8,415
+11% +$410K ﹤0.01% 2511
2021
Q2 		$3.86M Buy
79,613
+11,856
+17% +$567K ﹤0.01% 2621
2021
Q1 		$3.13M Buy
67,757
+37,301
+122% +$1.77M ﹤0.01% 2664
2020
Q4 		$1.45M Buy
30,456
+19,386
+175% +$879K ﹤0.01% 2926
2020
Q3 		$474K Sell
11,070
-29,527
-73% -$1.26M ﹤0.01% 3258
2020
Q2 		$1.66M Buy
40,597
+4,942
+14% +$199K ﹤0.01% 2701
2020
Q1 		$1.29M Buy
35,655
+3,787
+12% +$151K ﹤0.01% 2707
2019
Q4 		$1.36M Buy
31,868
+16,133
+103% +$640K ﹤0.01% 2929
2019
Q3 		$602K Buy
15,735
+8,265
+111% +$318K ﹤0.01% 3236
2019
Q2 		$291K Sell
7,470
-4,790
-39% -$182K ﹤0.01% 3488
2019
Q1 		$488K Buy
12,260
+3,310
+37% +$131K ﹤0.01% 3300
2018
Q4 		$326K Sell
8,950
-936
-9% -$36.8K ﹤0.01% 3328
2018
Q3 		$420K Sell
9,886
-838
-8% -$34K ﹤0.01% 3348
2018
Q2 		$414K Sell
10,724
-7,656
-42% -$277K ﹤0.01% 3305
2018
Q1 		$643K Buy
18,380
+2,335
+15% +$83.1K ﹤0.01% 3137
2017
Q4 		$586K Sell
16,045
-3,522
-18% -$127K ﹤0.01% 3161
2017
Q3 		$713K Buy
19,567
+1,148
+6% +$41.8K ﹤0.01% 3093
2017
Q2 		$675K Buy
18,419
+1,312
+8% +$46K ﹤0.01% 3114
2017
Q1 		$592K Buy
17,107
+2,808
+20% +$94.4K ﹤0.01% 3121
2016
Q4 		$454K Buy
14,299
+5,619
+65% +$188K ﹤0.01% 3318
2016
Q3 		$298K Buy
+8,680
New +$307K ﹤0.01% 3404
2014
Q4 		– Sell
-2,215
Closed -$85K – 3759
2014
Q3 		$85K Buy
2,215
+3
+0.1% +$110 ﹤0.01% 3745
2014
Q2 		$81K Buy
2,212
+1,512
+216% +$54.7K ﹤0.01% 3680
2014
Q1 		$26K Buy
+700
New +$25.8K ﹤0.01% 4068

Other funds holding BME

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
NRW
Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Ameriprise's BME Position: Q1 2026 in Review

Ameriprise reduced its BlackRock Health Sciences Trust (BME) stake by 0.85% in Q1 2026, selling an estimated $24.2K and leaving 68,984 shares worth $2.66M. The position accounts for ﹤0.01% of the portfolio, ranked #2819.

Ameriprise first reported a position in BME in Q1 2014 and has held it in 42 quarters since. The position peaked at $9.09M in Q2 2022. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • Ameriprise held 68,984 shares of BlackRock Health Sciences Trust worth $2.66M as of Q1 2026.
  • Ameriprise sold 588 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $24.2K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2819 holding.
  • Ameriprise first reported a position in BlackRock Health Sciences Trust in Q1 2014 and has held it in 42 quarters since.
  • Ameriprise's BlackRock Health Sciences Trust position peaked at $9.09M in Q2 2022.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.